11/08/2024
9:52 AM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
3:45 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
2:24 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
2:34 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
4:05 PM | Bjork Elisabeth (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:07 PM | Dolsten Mikael (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:05 PM | Dolsten Mikael (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
|
09/11/2024
3:06 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
3:26 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
2:29 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
2:39 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
2:16 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
2:23 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
3:15 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024
3:05 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
2:22 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:05 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
White Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
2:17 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
9:34 AM | Makker Gotham (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4/A | |
05/20/2024
3:33 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:36 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:39 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
SOUTHWELL DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:26 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:29 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:27 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
2:41 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
2:41 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
2:44 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
3:05 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
4:26 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:42 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form DEF 14A | |
04/29/2024
3:43 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form DEFA14A | |
04/29/2024
3:45 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form ARS | |
04/24/2024
3:06 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
2:18 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
4:26 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form PRE 14A | |
04/16/2024
4:45 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
SOUTHWELL DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:11 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
SOUTHWELL DAVID P (Reporting)
SOUTHWELL DAVID P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Urgent: This election is rigged (Ad) If you missed it, my emergency election broadcast is now available - but will be removed soon Click here to watch it now. |
04/10/2024
7:39 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
White Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
2:11 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
8:47 AM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
04/03/2024
5:02 PM | Ondrey Aaron (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:07 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Schwartz Jonathan David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/29/2024
4:17 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
7:54 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:58 PM | Makker Gotham (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
10:39 AM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
5:54 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:48 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
2:54 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
1:59 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:37 PM | ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
7:54 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:54 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
White Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:54 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:54 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:54 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
4:28 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
| Form 144/A | |
02/16/2024
3:31 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
3:37 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
3:22 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
3:26 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024
9:17 AM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
01/23/2024
3:22 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:05 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
2:16 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
10:43 AM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/12/2023
7:51 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Woods Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:42 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Woods Keith (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/16/2023
6:24 PM | Makker Gotham (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
5:58 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
6:09 PM | ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
6:17 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
2:21 PM | Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
2:21 PM | Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
2:28 PM | ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
